Keywords: Merck Serono, Merck KGaA, Saizen, Ready-to-use formulation, Europe

Merck Serono’s ready-to-use formulation of Saizen recommended for approval in Europe

Article | 16 November 2010

Print This

Switzerland-based Merck Serono, a division of German drug major Merck KGaA (MRK: DE) says that it has successfully completed the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in